Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 33 (KRT18P33) is a processed pseudogene related to the type I intermediate filament protein gene, keratin 18 (KRT18). Pseudogenes like KRT18P33 arise via duplication or retrotransposition events and typically lack the ability to encode functional proteins due to mutations or gene truncations. The human genome contains many processed pseudogenes for keratin genes, including dozens for KRT18, scattered across various chromosomes[7]. These pseudogenes are generally considered nonfunctional and are not therapeutic targets, biomarkers, or drug targets; they are also not directly associated with diseases or diagnostic uses[7]. The nomenclature and existence of pseudogenes such as KRT18P33 are mainly of interest for genomic annotation and evolutionary studies rather than biomedical research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 33 (KRT18P33).